Yuji Ishibashi
- Clinical Biochemistry top 0.5%
- Advanced Glycation End Products research 20
-
- Diabetes Treatment and Management 10
- Nephrology top 2%
- Chronic Kidney Disease and Diabetes 7
- Metals and Alloys top 10%
-
- Gastric Cancer Management and Outcomes 10
-
- Nuclear physics research studies 9
- Astronomical and nuclear sciences 6
-
- Gastrointestinal Tumor Research and Treatment 7
-
- Glycosylation and Glycoproteins Research 6
- Co-authors
- Takanori MatsuiSho‐ichi YamagishiMasayoshi TakeuchiSayaka MaedaYuichiro HigashimotoYuri NishinoKei FukamiAkiyoshi Taniguchi
- Journals
- Journal of Biological Chemistry (1 paper)Circulation (1 paper)SHILAP Revista de lepidopterología (4 papers)
- Partner nations
- JapanUnited StatesSouth Korea
In The Last Decade
Yuji Ishibashi
99 papers receiving 2.1k citations
Peers
Comparison fields: 5 of 120
- Clinical Biochemistry 510
- Endocrinology, Diabetes and Metabolism 785
- Nephrology 226
- Cardiology and Cardiovascular Medicine 326
- Metals and Alloys 27
Countries citing papers authored by Yuji Ishibashi
This map shows the geographic impact of Yuji Ishibashi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuji Ishibashi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuji Ishibashi more than expected).
Fields of papers citing papers by Yuji Ishibashi
This network shows the impact of papers produced by Yuji Ishibashi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuji Ishibashi. The network helps show where Yuji Ishibashi may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Yuji Ishibashi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2023 | 0 | |
| 3 | 2023 | 0 | |
| 4 | 2019 | 4 | |
| 5 | 2017 | 9 | |
| 6 | 2017 | 15 | |
| 7 | 2016 | 21 | |
| 8 | [A Case of Gemcitabine Refractory Lung Metastasis after Distal Pancreatectomy for Pancreatic Cancer, Effectively Treated with S -1 as Second Line Chemotherapy]. | 2015 | 0 |
| 9 | 2013 | 145 | |
| 10 | 2012 | 68 | |
| 11 | 2010 | 24 | |
| 12 | 2010 | 18 | |
| 13 | 2009 | 144 | |
| 14 | 2009 | 2 | |
| 15 | 2007 | 1 | |
| 16 | 2007 | 6 | |
| 17 | 2007 | 19 | |
| 18 | 2005 | 14 | |
| 19 | 1999 | 25 | |
| 20 | 1991 | 3 |
About Yuji Ishibashi
Yuji Ishibashi is a scholar working on Clinical Biochemistry, Gastroenterology and Nephrology, having authored 107 papers that have together received 2.2k indexed citations. Recurring topics across this work include Advanced Glycation End Products research (20 papers), Gastric Cancer Management and Outcomes (10 papers), Diabetes Treatment and Management (10 papers), Nuclear physics research studies (9 papers), Gastrointestinal Tumor Research and Treatment (7 papers), Chronic Kidney Disease and Diabetes (7 papers), Glycosylation and Glycoproteins Research (6 papers) and Astronomical and nuclear sciences (6 papers). The work is most often cited by research in Clinical Biochemistry (510 citations), Endocrinology, Diabetes and Metabolism (785 citations) and Nephrology (226 citations). Yuji Ishibashi has collaborated with scholars based in Japan, United States and South Korea. Frequent co-authors include Takanori Matsui, Sho‐ichi Yamagishi, Masayoshi Takeuchi, Sayaka Maeda, Yuichiro Higashimoto, Yuri Nishino, Kei Fukami, Akiyoshi Taniguchi, Ayako Ojima and Nobuo Nakada. Their work appears in journals such as Journal of Biological Chemistry, Circulation and SHILAP Revista de lepidopterología.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.